4QTE
Structure of ERK2 in complex with VTX-11e, 4-{2-[(2-CHLORO-4-FLUOROPHENYL)AMINO]-5-METHYLPYRIMIDIN-4-YL}-N-[(1S)-1-(3-CHLOROPHENYL)-2-HYDROXYETHYL]-1H-PYRROLE-2-CARBOXAMIDE
Summary for 4QTE
Entry DOI | 10.2210/pdb4qte/pdb |
Related | 4QTA 4QTB 4QTC 4QTD |
Descriptor | Mitogen-activated protein kinase 1, 1,2-ETHANEDIOL, SULFATE ION, ... (6 entities in total) |
Functional Keywords | structural genomics, structural genomics consortium, sgc, transferase, kinase, mapk, signalling, inhibitor, allosteric, structural genomics consortium (sgc), transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (human) |
Cellular location | Cytoplasm, cytoskeleton, spindle (By similarity): P28482 |
Total number of polymer chains | 1 |
Total formula weight | 43948.80 |
Authors | Chaikuad, A.,Savitsky, P.,von Delft, F.,Arrowsmith, C.H.,Edwards, A.M.,Bountra, C.,Knapp, S.,Structural Genomics Consortium (SGC) (deposition date: 2014-07-07, release date: 2014-07-23, Last modification date: 2023-09-20) |
Primary citation | Chaikuad, A.,M C Tacconi, E.,Zimmer, J.,Liang, Y.,Gray, N.S.,Tarsounas, M.,Knapp, S. A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics. Nat.Chem.Biol., 10:853-860, 2014 Cited by PubMed: 25195011DOI: 10.1038/nchembio.1629 PDB entries with the same primary citation |
Experimental method |
Structure validation
Download full validation report